Alamar Biosciences, Inc.
Fremont, CA Alamar Biosciecnes, Inc.
- UEI
- WM9YMMU3P233
- CAGE
- 87PS4
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 47071 Bayside Pkwy, Fremont, CA 94538, USA
- Website
- alamarbio.com
- Founded
- 2018
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Nimh: service: nulisaseq inflammation panel assay service: severable | Office of Logisitics and Acquisition Operations | $40,000 | |
| Nulisaseq neuro 220 panel. Multiplexed precision proteomics immunoassay panel for neurological disease biomarkers and… | Office of Logisitics and Acquisition Operations | $99,990 | |
| Alamar biosciences, INC.:1334504 [26-010199] | Office of Logisitics and Acquisition Operations | $57,080 | |
| Preventive maintenance and repair service - argo system proteomics equipment. | National Institute on Aging | $25,000 | |
| Alamar biosciences, INC.:1334504 [25-004811] purchase three (3) 120 CNS kits to be measured on the alamar nulisa… | National Institute on Drug Abuse | $30,000 |
About Alamar Biosciences, Inc.
Alamar Biosciences, Inc., a for-profit manufacturer of advanced biomedical research instruments and diagnostics based in Fremont, California, operates as a prime contractor delivering high-multiplex proteomic analysis platforms, reagent kits, laboratory testing services, and specialized biomarker research support to the National Institutes of Health and the Department of Veterans Affairs. The vendor competes exclusively in full-and-open procurements with no set-aside designations across its entire federal footprint.
Alamar Biosciences' capability portfolio centers on proteomics platforms, particularly the NULISA and ARGO HT systems for measuring disease biomarkers in plasma and tissue samples. Recent representative work includes a $2.75 million firm-fixed-price purchase order from the National Institute on Aging (NIA) awarded September 2024 for the ARGO HT Instrument and NULISASEQ CNS Disease Panel; a $510,365.60 order from the Veterans Integrated Service Network 7 at the Department of Veterans Affairs awarded September 2025 for a high-multiplex proteomic platform supporting burn pit exposure research at the Atlanta VA Medical Center; and a $324,000 order from NIA awarded April 2025 for NULISASEQ Inflammation Panel 250 reagents with proteomic analysis and sequencing services. The vendor also supplies single-plex assay kits, mouse panel analysis, and laboratory testing services across multiple NIH components.
Customer concentration is heavily skewed toward the National Institute on Aging, which accounts for 5 awards and $3.4 million (83% of combined potential value) across the ten-award footprint. The National Institute on Drug Abuse places three awards totaling $187 thousand, the Veterans Health Administration one award of $510 thousand, and the National Institute of Mental Health one award of $20 thousand. All four customer agencies are housed within or affiliated with the Department of Health and Human Services or the Department of Veterans Affairs. The source does not identify parent vehicles, IDIQs, GWACs, or BPAs; all ten awards are individual purchase orders placed directly by the customer agencies.
Activity is nascent but growing. The vendor recorded four awards in 2024, five in 2025, and one in 2026 through mid-February. Combined obligated dollars equal the combined potential value of $4.1 million, indicating 100% obligation across the footprint. Only two awards (combined potential value $125 thousand) face ultimate completion dates within the next twenty-four months, presenting minimal near-term recompete exposure. The vendor has no identified subcontract footprint and operates exclusively as a prime on direct-award purchase orders.
Quick answers
What is Alamar Biosciences, Inc.'s UEI?
Alamar Biosciences, Inc.'s Unique Entity ID (UEI) in SAM.gov is WM9YMMU3P233.
What is Alamar Biosciences, Inc.'s CAGE code?
Alamar Biosciences, Inc.'s CAGE code is 87PS4.
What is Alamar Biosciences, Inc.'s primary NAICS code?
Alamar Biosciences, Inc.'s primary NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing).
Where is Alamar Biosciences, Inc. located?
Alamar Biosciences, Inc.'s physical address in SAM.gov is 47071 Bayside Pkwy, Fremont, CA 94538, USA.
Is Alamar Biosciences, Inc. registered in SAM.gov?
Yes. Alamar Biosciences, Inc.'s SAM.gov registration is active through January 23, 2027.
What is Alamar Biosciences, Inc.'s most recent federal award?
Alamar Biosciences, Inc.'s most recent federal contract award is Nimh: service: nulisaseq inflammation panel assay service: severable (75N98026P01744), from Office of Logisitics and Acquisition Operations, on September 21, 2026.
On GovTribe
See Alamar Biosciences, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors